Age, Biography and Wiki

Ashraf Brik was born on 29 June, 1973 in Abu Snan, Israel, is a researcher. Discover Ashraf Brik's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 50 years old?

Popular As N/A
Occupation N/A
Age 51 years old
Zodiac Sign Cancer
Born 29 June 1973
Birthday 29 June
Birthplace Abu Snan, Israel
Nationality Israel

We recommend you to check the complete list of Famous People born on 29 June. He is a member of famous researcher with the age 51 years old group.

Ashraf Brik Height, Weight & Measurements

At 51 years old, Ashraf Brik height not available right now. We will update Ashraf Brik's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Ashraf Brik Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is Ashraf Brik worth at the age of 51 years old? Ashraf Brik’s income source is mostly from being a successful researcher. He is from Israel. We have estimated Ashraf Brik's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income researcher

Ashraf Brik Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

2020

The research efforts of Brik's group are budgeted by many foundations, including the European Commission's Horizon 2020 Program, which recently awarded him the ERC Advanced Grant.

2007

In 2007 Brik joined the Department of Chemistry of Ben Gurion University of the Negev. In 2011 he was promoted to associate professor and in 2012 to full professor. In 2014, Brik moved to the Technion Institute of Technology, where he holds the Jordan and Irene Tark Chair. Brik has coauthored more than 120 publications in key periodicals: Science, Nature Chemistry, Nature Chemical Biology, Nature Protocols, Journal of the American Chemical Society, Angewandte Chemie, Chemical Society Reviews, Chemical Science and others. Brik is a member of advisory and editing boards of a number of periodicals, including Cell Chemical Biology, ChemBioChem and Organic and Biomolecular Chemistry. He has also registered 6 patents.

2004

Brik, one of ten children, was born and raised in Abu Snan in northern Israel. He received a bachelor's degree in chemistry from Ben-Gurion University of the Negev, a master's degree in chemistry from the Technion. He studied for his doctoral degree, in which he focused on research of chemical synthesis of proteins, from a joint course of the Technion and the Scripps Research Institute under the mentorship of Professor Chi-Huey Wong. Brik authored the thesis “Design and Synthesis of Novel Catalytic Proteins Based on Polypeptide Scaffolds”, under the supervision of professor Ehud Keinan (Technion) and professor Phillip Dawson (The Scripps Research Institute). He was promoted to senior researcher in 2004. He developed the synthesis of glycoproteins. In addition, Brik was involved in projects related to the discovery of inhibitors of various enzymes such as HIV protease.

1973

Ashraf Brik (Hebrew: אשרף בריק, Arabic: أشرف بريق; born June 29, 1973) is a full professor at the Schulich Faculty of Chemistry at the Technion Institute of Technology, Israel. His laboratory specializes in developing synthetic methods for chemical synthesis of proteins with post-translational modifications (PTMs) in quantities that allow for them to be studied thoroughly. Brik's group is developing novel modulators based on small molecules, peptides and peptidomimetics, to influence enzymes (such as deubiquitinases) and proteins involved in various diseases. With the help of these tools, it is possible to understand how molecules and biological systems affect health.